Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma

Affiliations

• ¹ Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
• ² Department of Hematology and Bone Marrow Transplantation, Pomeranian Hospitals, Gdynia, Poland.
• ³ Oncologic Hospital, Tomaszów Mazowiecki, Poland.
• ⁴ Department of Oncology, Oncology Centre, Bydgoszcz, Poland.
• ⁵ Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
• ⁶ Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw branch, Warsaw, Poland.
• ⁷ Department of Hematology, Independent Public Health Care Ministry of the Interior of Warmia and Mazury Oncology Center, Olsztyn, Poland.
• ⁸ Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland.
• ⁹ Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland.
• ¹⁰ Department of Hematology, Jagiellonian University, Krakow, Poland.
• ¹¹ InternalMedicine and Oncology Clinic, Silesian Medical University, Katowice, Poland.
• ¹² Department of Hematology, Military Institute of Medicine, Warsaw, Poland.
• ¹³ Department of Hematology, Ludwik Rydygier Hospital, Krakow, Poland.
• ¹⁴ Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
• ¹⁵ Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland. jzaucha@gumed.edu.pl.